Abstract
Many cases of male breast cancer (MBC) have been diagnosed during recent years. The increased incidence of such a mortal disease has pointed out the need for solid and well-defined protocols in order to obtain early diagnosis, effective treatment, as well as a greater long-term survival. Although many similarities with female breast cancer support similar diagnostic and therapeutic paths, recent findings about MBC cell phenotypes and tumor behavior support the need for a more customized ai, t, i, ar. One thing is though sure: nowadays lack of knowledge about MBC needs to stimulate further research and the introduction of more standardized and univocal diagnostic/therapeutic guidelines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101:51–7.. https://doi.org/10.1002/cncr.20312
Anderson WF, Jatoi I, Tse J, Rosenberg PS. Male breast cancer: a population-based comparison with female breast cancer. J Clin Oncol. 2010;28:232–9. https://doi.org/10.1200/JCO.2009.23.8162.
Li X, Yang J, Krishnamurti U, Huo L, Ward KC, O’Regan R, et al. Hormone receptor-positive breast cancer has a worse prognosis in male than in female patients. Clin Breast Cancer. 2017;5:356–66. https://doi.org/10.1016/j.clbc.2017.03.005.
Fentiman IS. Male breast cancer: a review. Ecancermedicalscience. 2009;3:140. https://doi.org/10.3332/ecancer.2009.140.
Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol. 24:1434–43. https://doi.org/10.1093/annonc/mdt025.
Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–8.
Rayson D, Erlichman C, Suman VJ, Roche PC, Wold L, Ingle JN, et al. Molecular markers in male breast carcinoma. Cancer. 1998;83:1947–55. https://doi.org/10.1002/(sici)1097-0142(19981101)83:9<1947::aid-cncr10>3.0.co;2-j.
Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R, et al. Male breast cancer in the veterans affairs population: a comparative analysis. Cancer. 2007;109:1471–7. https://doi.org/10.1002/cncr.22589.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41. https://doi.org/10.1056/NEJMoa022152.
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2001;347:1227–32. https://doi.org/10.1056/NEJMoa020989.
Margaria E, Chiusa L, Dal Canton O, Pich A. Therapy and survival in male breast carcinoma: a retrospective analysis of 50 cases. Oncol Rep. 2000;7:1035–9.
Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer. 1999;85:629–39.
Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother. 2007;8:193–202. https://doi.org/10.1517/14656566.8.2.193.
Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer. 1995;31:1960–4.
Borgen PI, Wong GY, Vlamis V, Potter C, Hoffmann B, Kinne DW, et al. Current management of male breast cancer: a review of 104 cases. Ann Surg. 1992;215:451–9.
Elmi M, Sequeira S, Azin A, Elnahas A, McCready DR, Cil TD. Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database. Breast Cancer Res Treat. 2018;171(2):427–34. https://doi.org/10.1007/s10549-018-4830-y.
Fields EC, DeWitt P, Fisher CM, Rabinovitch R. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis MD. Int J Rad Oncol Biol Phys. 2013;87:747–52.
Zaenger D, Rabatic BM, Dasher B, Mourad WF. Is breast conserving therapy a safe modality for early-stage male breast cancer? Clin Breast Cancer. 2016:101–4. https://doi.org/10.1016/j.clbc.2015.11.005.
Cloyd JM, Hernandez-Boussard T, Wapnir IL. Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983–2009. Ann Surg Oncol. 2013;5:1545–50. https://doi.org/10.1245/s10434-013-2918-5.
Golsham M, Rusby J, Dominguez F, Smith BL. Breast conservation for male breast carcinoma. Breast. 2007;16:653–6. https://doi.org/10.1016/j.breast.2007.05.012.
Donegan W, Spratt J. Cancer of the breast. In: Male breast cancer. 5th ed. Philadelphia: Saunders; 2002. p. 951–8. https://doi.org/10.1186/bcr764.
Simos D, Catley C, van Walraven C, Arnaout A, Booth CM, McInnes M, et al. Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study. CMAJ. 2015;187:E387–97. https://doi.org/10.1503/cmaj.150003.
Port ER, Fey JV, Cody HS, Borgen PI. Sentinel lymph node biopsy in patients with male breast cancer. Cancer. 2001;91:319–23. https://doi.org/10.1634/theoncologist.12-5-512.
Auvinen A, Curtis RE, Ron E. Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst. 2002;94:1330–2. https://doi.org/10.1093/jnci/94.17.1330.
Jemal A, Lin CC, DeSantis C, Sineshaw H, Freedman RA. Temporal trends in and factors associated with contralateral prophylactic mastectomy among US men with breast cancer. JAMA Surg. 2015;150:1192–4. https://doi.org/10.1001/jamasurg.2015.2657.
Özkurt E, Tükenmez M, Yılmaz R, Cabioğlu N, Müslümanoğlu M, SaidDinççağ A, et al. Favorable long-term outcome in male breast cancer. Eur J Breast Health. 2018;14:180–5. https://doi.org/10.5152/ejbh.2018.3946.
Flynn LW, Park J, Patil SM, Cody HS 3rd, Port ER. Sentinel lymph node biopsy is successful and accurate in male breast carcinoma. J Am Coll Surg. 2008;206:616–21. https://doi.org/10.1016/j.jamcollsurg.2007.11.005.
Gentilini O, Chagas E, Zurrida S, Intra M, De Cicco C, Gatti G. Sentinel lymph node biopsy in male patients with early breast cancer. Oncologist. 2007;12:512–5. https://doi.org/10.1634/theoncologist.12-5-512.
Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez KA, McTiernan A, Stemhagen A, Thompson WD, McCrea Curnen MG, Satariano W, Austin DF, Greenberg RS, Key C, Kolonel L, West D.
Stalsberg H, Thomas DB, Rosenblatt KA, Jimenez LM, McTiernan A, Stemhagen A, et al. Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men. Cancer Causes Control. 1993;4:143–51.
Agrawal A, Ayantunde AA, Rampaul R, Robertson JF. Male breast cancer: a review of clinical management. Breast Cancer Res Treat. 2007;103:11–21. https://doi.org/10.1007/s10549-006-9356-z.
Gunhan-Bilgen I, Bozkaya H, Ustun E, Memis A. Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol. 2002;43:246–55. https://doi.org/10.1016/S0720-048X(01)00483-1.
Losurdo A, Rota S, Gullo G, Masci G, Torrisi R, Bottai G, et al. Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: a review of the literature. Crit Rev Oncol Hematol. 2017;113:283–91. https://doi.org/10.1016/j.critrevonc.2017.03.013.
Giordano SH. Breast cancer in men. N Engl J Med. 2018;378:2311–20. https://doi.org/10.1056/NEJMra1707939.
Fentiman IS. Surgical options for male breast cancer. Breast Cancer Res Treat. 2018;172:539–44. https://doi.org/10.1007/s10549-018-4952-2.
Rudlowski C. Male breast cancer. Breast Care (Basel). 2008;3:183–9. https://doi.org/10.1159/000136825.
Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM, Akins JS, et al. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006;203:475–80. https://doi.org/10.1503/2Fcjs.006010.
Acknowledgments
Disclosure: None of the authors has a financial interest in any of the products or devices mentioned in this chapter. No funding was received.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zabbia, G., De Michele, F. (2020). Male Breast Cancer: Oncologic Surgery. In: Cordova, A., Innocenti, A., Toia, F., Tripoli, M. (eds) Plastic and Cosmetic Surgery of the Male Breast. Springer, Cham. https://doi.org/10.1007/978-3-030-25502-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-25502-2_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25501-5
Online ISBN: 978-3-030-25502-2
eBook Packages: MedicineMedicine (R0)